var data={"title":"Acinetobacter infection: Epidemiology, microbiology, pathogenesis, clinical features, and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Acinetobacter infection: Epidemiology, microbiology, pathogenesis, clinical features, and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Zeina A Kanafani, MD, MS</a></dd><dd><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Souha S Kanj, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Allyson Bloom, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 12, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter is a gram-negative coccobacillus that has emerged from an organism of questionable pathogenicity to an infectious agent of importance to hospitals worldwide [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. The organism has the ability to accumulate diverse mechanisms of resistance, leading to the emergence of strains that are resistant to all commercially-available antibiotics [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>The microbiology, pathogenesis, epidemiology, and disease associations of Acinetobacter infection will be reviewed here. The treatment and prevention of Acinetobacter infection are discussed separately. (See <a href=\"topic.htm?path=acinetobacter-infection-treatment-and-prevention\" class=\"medical medical_review\">&quot;Acinetobacter infection: Treatment and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology of Acinetobacter infections is broad and includes infection associated with tropical environments, wars and natural disasters, and hospital outbreaks in temperate climates [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/3-7\" class=\"abstract_t\">3-7</a>]. It naturally inhabits water and soil, and other possible reservoirs include pets, arthropods, and food animals [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/5,8-10\" class=\"abstract_t\">5,8-10</a>]. In humans, Acinetobacter can colonize skin, wounds, and the respiratory and gastrointestinal tracts [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>]. It can also inhabit oral biofilms, predisposing to pneumonia in the event of aspiration into the lower respiratory tract [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12,13\" class=\"abstract_t\">12,13</a>]. </p><p>Some Acinetobacter strains can survive environmental desiccation for weeks, a characteristic that promotes transmission through fomite contamination in hospitals [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/14-16\" class=\"abstract_t\">14-16</a>]. </p><p class=\"headingAnchor\" id=\"H960943695\"><span class=\"h2\">Association with climate</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Historically, Acinetobacter has been a pathogen of humid climates. Years before Acinetobacter became a concern in intensive care units (ICUs) in the United States, it was cited as the cause of 17 percent of cases of ventilator-associated pneumonias in a Guatemalan ICU, second only to Pseudomonas, which caused 19 percent of cases [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>]. </p><p>Since the 1970s, Acinetobacter infections have become an increasingly common nosocomial problem in temperate climates [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/18\" class=\"abstract_t\">18</a>]. Their emergence is likely related in part to their survival ability and their rapid development of resistance to the major antibiotic classes [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>]. </p><p>Nevertheless, nosocomial Acinetobacter infections have been observed more frequently in the summer than in other seasons; in one review of 3447 Acinetobacter infections reported to the United States Centers for Disease Control and Prevention (CDC) between 1987 and 1996, infection rates were approximately 50 percent higher from July to October than at other times of the year [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. Possible explanations include more humid ambient air (which favors growth of Acinetobacter in its natural habitats) and potentially preventable environmental contaminants, such as condensate from air-conditioning units, which have been implicated as a cause of epidemic Acinetobacter infections.</p><p class=\"headingAnchor\" id=\"H960943549\"><span class=\"h2\">Disease associations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter is most notorious for its association with health care-associated infections, particularly among patients in the intensive care unit (ICU). However, it has also been associated with community-acquired infections in Asia and Australia as well as infections related to wars and natural disasters.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Health care-associated infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter is an important cause of hospital-acquired infections globally. A 2008 report from the United States, the National Healthcare Safety Network (NHSN), reviewed the most frequent types of hospital-acquired infections in intensive care units due to gram-negative bacilli [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]. Acinetobacter species, most often A. baumannii, accounted for the following proportion of gram-negative isolates: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ventilator-associated pneumonia isolates &ndash; 8.4 percent </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central line-associated bloodstream infection isolates &ndash; 2.2 percent </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Catheter-associated urinary tract infection isolates &ndash; 1.2 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Surgical site infection isolates &ndash; 0.6 percent </p><p/><p>Infections with A. baumannii tend to occur in debilitated patients in ICUs (among both children and adults) [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>] and among residents of long-term care facilities (particularly facilities caring for ventilator-dependent patients). Additional risk factors include recent surgery, central vascular catheterization, tracheostomy, mechanical ventilation, enteral feeding, and treatment with third generation cephalosporin, fluoroquinolone, or carbapenem antibiotics [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/1,23-25\" class=\"abstract_t\">1,23-25</a>]. Risk factors among neonates include low birth weight, <a href=\"topic.htm?path=total-parenteral-nutrition-drug-information\" class=\"drug drug_general\">total parenteral nutrition</a>, and central venous catheters [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/26,27\" class=\"abstract_t\">26,27</a>]. Most information about health care-associated Acinetobacter infections is based on data from outbreak investigations [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>]. </p><p>Acinetobacter outbreaks have also been traced to common-source contamination (particularly contaminated respiratory and ventilator equipment), and to cross-infection by the hands of health care workers caring for colonized or infected patients [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/17,28,29\" class=\"abstract_t\">17,28,29</a>]. Once Acinetobacter is introduced into a hospital, serial or overlapping outbreaks caused by various multidrug-resistant strains are frequently observed. Subsequently, endemicity of multiple strains is established, with a single endemic strain predominating at any one time [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>]. Prolonged colonization may contribute to the endemicity of A. baumannii after an outbreak; in one study, colonization persisted for up to 42 months and affected 17 percent of patients [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p>Dramatic multihospital outbreaks have been described in the United States, Europe, South America, Africa, Asia, and the Middle East [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/2,24,31,32\" class=\"abstract_t\">2,24,31,32</a>]. As an example, a monoclonal outbreak of a carbapenemase producing (OXA-40) Acinetobacter was described in the greater Chicago area in 2005; subsequently, at least five hospitals, three long-term care facilities, and more than 200 patients were affected by this outbreak [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>].</p><p>The occurrence of monoclonal outbreaks in multiple hospitals suggests spread between institutions, presumably by movements of patients or personnel, or by exposure to common-source contamination of food or equipment. Such outbreaks highlight the importance of ongoing surveillance and measures to prevent the introduction of Acinetobacter into, and spread from, long term care facilities.</p><p>Data regarding the prognosis of patients with Acinetobacter infections are limited. While such patients usually have high mortality rates [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>], it is unclear whether mortality can be attributed to Acinetobacter infection. In a matched cohort study of trauma patients, the effect of Acinetobacter infections on mortality was inconclusive [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/34\" class=\"abstract_t\">34</a>]. Cases had a longer stay in the intensive care unit and a higher rate of organ failure than control patients with infections other than Acinetobacter. Risk factors for mortality in patients with Acinetobacter infections include <a href=\"topic.htm?path=imipenem-and-cilastatin-drug-information\" class=\"drug drug_general\">imipenem</a> resistance, intensive care unit stay, female gender, old age, pneumonia, diabetes mellitus, and septic shock [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/35,36\" class=\"abstract_t\">35,36</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Community-acquired infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Community acquired Acinetobacter infection has been reported in Australia and Asia; in Australia, community-acquired pneumonia occurs more frequently during the wet (monsoon) season [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/3,4,6,37\" class=\"abstract_t\">3,4,6,37</a>]. In tropical northern Australia, A. baumannii accounts for 10 percent of cases of severe community-acquired pneumonia [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/38\" class=\"abstract_t\">38</a>]. </p><p>Community-acquired infections have been characterized by pharyngeal carriage of the organism, aggressive pneumonia, and high case fatality rates. Risk factors include tobacco use, chronic obstructive pulmonary disease, diabetes, alcoholism, and cancer [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/3,4,37,38\" class=\"abstract_t\">3,4,37,38</a>]. Community-acquired bloodstream infections have also been observed [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/4,37,39\" class=\"abstract_t\">4,37,39</a>].</p><p>In the United States, community-acquired infections are rare [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. The reason for the higher prevalence of Acinetobacter infections in certain geographic areas is not known, but it may be due in part to differences in temperature and humidity that influence colonizing bacteria.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Wars and natural disasters</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter should be included in the differential diagnosis of infections sustained among deployed military personnel and following exposure to natural disasters in a tropical environment.</p><p>Wartime Acinetobacter infections have been reported during the Korean War, the Vietnam War, and the wars in Iraq and Afghanistan, and resistance rates are high [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/41-45\" class=\"abstract_t\">41-45</a>]. In one study, A. baumannii accounted for 63 percent of all bacterial isolates recovered from war wounds in US troops situated in Iraq and Afghanistan between 2007 and 2008 [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>].According to another report, Acinetobacter isolates from military personnel had a lower rate of susceptibility to <a href=\"topic.htm?path=imipenem-and-cilastatin-drug-information\" class=\"drug drug_general\">imipenem</a> than isolates from non-deployed personnel (63 versus 87 percent) [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>].</p><p>The genetic variability and reappearance of Acinetobacter in personnel participating in several military operations over several decades suggests multiple sources, including local foods, battlefield wound contamination, and environmental spread and cross-infection in field and referral hospitals [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/42,47,48\" class=\"abstract_t\">42,47,48</a>].</p><p>The prevalence of Acinetobacter infections has also been disproportionately high in the setting of natural disasters. Among 17 patients evacuated in critical condition due to soft tissue injuries and fractures after the Southeast Asia tsunami in 2004, multi-drug resistant Acinetobacter was isolated from 20 percent of wounds, as well as from blood and respiratory secretions [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/49\" class=\"abstract_t\">49</a>]. Following the 1999 Marmara earthquake in Turkey, A. baumannii was the most prevalent nosocomial pathogen in a Turkish ICU, where it had only rarely been isolated previously [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/50\" class=\"abstract_t\">50</a>].</p><p class=\"headingAnchor\" id=\"H962039848\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The genus Acinetobacter comprises gram-negative coccobacilli that are non-motile, strictly aerobic, catalase-positive, and oxidase-negative [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/51\" class=\"abstract_t\">51</a>]. It had previously encompassed a heterogeneous collection of non-pigmented, oxidase-positive and oxidase-negative gram-negative rods [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/52,53\" class=\"abstract_t\">52,53</a>].</p><p>Acinetobacter is easily isolated in standard cultures, although identification can be delayed since it is relatively nonreactive in many biochemical tests commonly used to differentiate among gram-negative bacilli. Acinetobacter species appear as short, broad gram-negative rods in the rapid growth phase but assume a more coccobacillary shape in the stationary phase. They are indole-negative and do not ferment glucose or reduce nitrate.</p><p>More than 30 different species belonging to the genus Acinetobacter have been identified [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/54,55\" class=\"abstract_t\">54,55</a>]. Most of these species are environmental organisms and have not been associated with human disease [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. A. baumannii, A. calcoaceticus and A. lwoffi are the species most frequently reported in the clinical literature. The term A. calcoaceticus-A. baumannii complex (ACB) is sometimes used since it is difficult to differentiate among Acinetobacter species on the basis of phenotypic characteristics [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/57\" class=\"abstract_t\">57</a>]. The ACB is comprised of genospecies 1 (A. calcoaceticus), genospecies 2 (A. baumannii), genospecies 3, and genospecies 13TU [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/58-60\" class=\"abstract_t\">58-60</a>]. </p><p>Acinetobacter baumannii (genospecies 2 of the ACB complex) is the most resistant of the genospecies and has the greatest clinical importance [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/61\" class=\"abstract_t\">61</a>]. This pathogen is the most frequently isolated species (&gt;90 percent of Acinetobacter spp isolates) and is typically associated with outbreaks in the hospital setting. It is characterized by its resistance to harsh environment factors, a property that enables such organisms to spread rapidly and develop resistance to all conventional antimicrobials [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/55,62\" class=\"abstract_t\">55,62</a>]. Other species that have been associated with disease include A. johnsonii, A. lwoffi, and A. calcoaceticus subsp anitratus [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/63\" class=\"abstract_t\">63</a>]. More recently, A. junii has been described as an opportunistic pathogen in the setting of prior antimicrobial therapy, invasive procedures, and malignancy [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/64\" class=\"abstract_t\">64</a>].</p><p class=\"headingAnchor\" id=\"H962039894\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Five main pathogenic mechanisms have thus far been described:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Biofilm formation &mdash; Colonization of environmental surfaces is promoted by adhesion via pili and the subsequent formation of biofilms [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/63\" class=\"abstract_t\">63</a>]. Biofilm-associated protein (Bap) is needed for biofilm maintenance and maturation [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. Bap is also important for colonization as it facilitates adherence to cells [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. High biofilm producing strains are less sensitive to desiccation than low biofilm producing strains; thus, biofilm production seems critical for Acinetobacter&rsquo;s well-established ability to survive under dry conditions [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/65\" class=\"abstract_t\">65</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Outer membrane protein A (OmpA) &mdash; Production of OmpA is essential for making an intact biofilm [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. It is also essential for adherence to epithelial cells. It induces cell apoptosis by entering the cell and stimulating the release of cytochrome c and apoptosis-inducing factor. OmpA also helps bind Factor H, which is an inhibitor of the alternative complement pathway [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>K1 capsule &mdash; Approximately one-third of strains produce a polysaccharide capsule that works with the cell wall liposaccharide to prevent complement activation [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/66\" class=\"abstract_t\">66</a>]. The capsule may also delay phagocytosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Siderophore-mediated iron-acquisition system &mdash; Acinetobacter can survive iron-deficient conditions [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/67\" class=\"abstract_t\">67</a>] for long periods of time. This is due to its &quot;acinetobactin,&quot; a catechol siderophore that can sequester iron from the host [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fimbriae &mdash; As mentioned above, fimbriae help attach the organism to environmental surfaces. They also help colonize biotic surfaces, such as bronchial epithelial cells [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/62\" class=\"abstract_t\">62</a>].</p><p/><p class=\"headingAnchor\" id=\"H688208535\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most frequent clinical manifestations of Acinetobacter infection are ventilator-associated pneumonia and bloodstream infections [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/57\" class=\"abstract_t\">57</a>]. Additionally, in humans, Acinetobacter can colonize skin, wounds, and the respiratory and gastrointestinal tracts [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>]. It may be difficult to distinguish between colonization and true infection, particularly since many infections occur in the setting of colonization. </p><p class=\"headingAnchor\" id=\"H688209418\"><span class=\"h2\">Hospital-acquired pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter pneumonia occurs predominantly in intensive care unit (ICU) patients who require mechanical ventilation and tends to be characterized by a late onset. Other clinical manifestations of Acinetobacter pneumonia are similar to those reported for hospital-acquired pneumonia in general. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnostic-evaluation-of-ventilator-associated-pneumonia#H2632276373\" class=\"medical medical_review\">&quot;Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia&quot;, section on 'When to suspect ventilator-associated pneumonia'</a>.)</p><p>Most cases of nosocomial Acinetobacter pneumonia occur in previously colonized patients. True Acinetobacter pneumonia must be distinguished from airway colonization in mechanically ventilated patients. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnostic-evaluation-of-ventilator-associated-pneumonia#H2756495\" class=\"medical medical_review\">&quot;Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia&quot;, section on 'Diagnostic evaluation'</a>.)</p><p>A. baumannii was among the most common pathogens causing nosocomial pneumonia in a prospective observational study from 27 ICUs in nine different European countries; in Greece and Turkey, it was the most common isolate [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/68\" class=\"abstract_t\">68</a>]. Nosocomial pneumonia secondary to Acinetobacter is associated with mortality rates of 35 to 70 percent, although attributable mortality is difficult to determine since most patients have concurrent life-threatening conditions [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/3,25,69-71\" class=\"abstract_t\">3,25,69-71</a>]. Coexisting conditions appear to be a major predictor of outcome [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/25,72-74\" class=\"abstract_t\">25,72-74</a>]. One study noted higher mortality among patients with infection due to multidrug-resistant Acinetobacter than among patients with infection due to susceptible Acinetobacter strains or uninfected patients; however, when the severity of illness and underlying diseases were considered, the main difference was that patients with multidrug-resistant infection had longer hospital and ICU stays [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/72\" class=\"abstract_t\">72</a>]. </p><p>Overall, positive blood cultures and signs of sepsis usually portend a bad prognosis [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/74,75\" class=\"abstract_t\">74,75</a>]. As an example, severe sepsis and septic shock were independent predictors or 30-day mortality in a study of patients with nosocomial A. <span class=\"nowrap\">baumannii/calcoaceticus</span> complex pneumonia [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/75\" class=\"abstract_t\">75</a>]. Additionally, patients with pneumonia due to Acinetobacter spend more ventilator days in the ICU before detection of positive cultures than do patients with pneumonia due to other gram-negative bacilli or uninfected patients [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H688209430\"><span class=\"h2\">Community-acquired pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Community-acquired Acinetobacter pneumonia is typically characterized by a fulminant illness with an abrupt onset and rapid progression to respiratory failure and hemodynamic instability [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/3,4,6\" class=\"abstract_t\">3,4,6</a>]. Septic shock ensues in around one-third of patients. This infection seems to be more common in Southeast Asia and Australia compared with other regions and has been increasingly reported as a highly fatal disease [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/76\" class=\"abstract_t\">76</a>]. </p><p class=\"headingAnchor\" id=\"H688209436\"><span class=\"h2\">Bloodstream infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter accounts for 1.5 to 2.4 percent of nosocomial bloodstream infections [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/77-79\" class=\"abstract_t\">77-79</a>]. The most frequent sources of Acinetobacter bacteremia are vascular catheters and the respiratory tract [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/78,80,81\" class=\"abstract_t\">78,80,81</a>]. Less common primary sites include wounds and the urinary tract. In one study, approximately 36 percent of 111 cases of Acinetobacter bloodstream infections were polymicrobial and included skin flora, suggesting that some blood isolates represented contamination from the skin or environment [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/78\" class=\"abstract_t\">78</a>].</p><p>Risk factors for Acinetobacter bloodstream infection include intensive care, mechanical ventilation, prior surgery, prior use of broad-spectrum antibiotics, immunosuppression, trauma, burns, malignancy, central venous catheters, invasive procedures, and prolonged hospital stay [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/78-80,82-85\" class=\"abstract_t\">78-80,82-85</a>].</p><p>Septic shock develops in up to one-third of patients with Acinetobacter bacteremia [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/81,82\" class=\"abstract_t\">81,82</a>]; mortality ranges from 20 to 60 percent, although the mortality attributable to bacteremia itself is difficult to determine in the setting of multiple comorbidities [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/74,78,80-82,86,87\" class=\"abstract_t\">74,78,80-82,86,87</a>]. Bacteremia associated with Acinetobacter pneumonia is associated with higher mortality than bacteremia associated with catheter infection (39 versus 4 percent, respectively) [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/80,82\" class=\"abstract_t\">80,82</a>]. In addition, multidrug resistance and mechanical ventilation have been associated with 30-day mortality in patients with A. baumannii bacteremia [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/88\" class=\"abstract_t\">88</a>]. </p><p>Other clinical manifestations of Acinetobacter bloodstream infection are similar to those reported for gram-negative bacillary bacteremia in general. (See <a href=\"topic.htm?path=gram-negative-bacillary-bacteremia-in-adults#H7\" class=\"medical medical_review\">&quot;Gram-negative bacillary bacteremia in adults&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H688209442\"><span class=\"h3\">Endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter spp are a rare cause of infective endocarditis in native and prosthetic heart valves [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/89-92\" class=\"abstract_t\">89-92</a>]. In a study of 171 patients with prosthetic heart valve endocarditis resulting from nosocomial bacteremia, two cases were attributable to Acinetobacter [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/93\" class=\"abstract_t\">93</a>]. Acinetobacter endocarditis is typically characterized by acute onset with an aggressive course. Mortality tends to be higher in the setting of native valve endocarditis than prosthetic valve endocarditis, likely because of the low index of suspicion leading to delayed treatment in such cases [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/89\" class=\"abstract_t\">89</a>]. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-prosthetic-valve-endocarditis#H9\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H688209448\"><span class=\"h2\">Meningitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter is an infrequent cause of nosocomial meningitis [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/94-96\" class=\"abstract_t\">94-96</a>]. Among 95 cases of meningitis following craniotomy, two were due to Acinetobacter spp [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/94\" class=\"abstract_t\">94</a>]. Risk factors include neurosurgical procedures, cerebrospinal fluid (CSF) leak, prior antibiotic therapy, and intracranial hemorrhage [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/97-99\" class=\"abstract_t\">97-99</a>]. Nosocomial outbreaks of Acinetobacter meningitis have been reported in association with the intrathecal administration of contaminated <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a> [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/100\" class=\"abstract_t\">100</a>] and with contaminated suctioning equipment in a neurosurgical unit [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/101\" class=\"abstract_t\">101</a>]. Mortality ranges from 20 to 30 percent; neurologic deficits in surviving patients can be severe [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/95,99,102\" class=\"abstract_t\">95,99,102</a>]. </p><p>Community-acquired Acinetobacter meningitis is rare; it primarily occurs in previously healthy individuals in warm climates, and is usually not drug resistant [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/103\" class=\"abstract_t\">103</a>].</p><p>Most patients with Acinetobacter meningitis present with fever, meningeal signs, <span class=\"nowrap\">and/or</span> seizures. Cerebral spinal fluid (CSF) typically demonstrates pleocytosis with neutrophilic predominance, elevated protein concentration, and a low CSF-to-serum glucose ratio [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/97,98\" class=\"abstract_t\">97,98</a>]. Other clinical manifestations of Acinetobacter central nervous system infections are similar to those reported for meningitis in general. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-acute-bacterial-meningitis-in-adults\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of acute bacterial meningitis in adults&quot;</a> and <a href=\"topic.htm?path=gram-negative-bacillary-meningitis-treatment\" class=\"medical medical_review\">&quot;Gram-negative bacillary meningitis: Treatment&quot;</a>.)</p><p>Skin contamination with Acinetobacter can be mistaken for true infection [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/98,104\" class=\"abstract_t\">98,104</a>]. In a retrospective analysis of 54 patients with CSF cultures growing Acinetobacter, the organism was considered clinically insignificant in 34 (63 percent) [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/98\" class=\"abstract_t\">98</a>]. The isolation of Acinetobacter from multiple CSF specimens and the typical clinical and laboratory findings of bacterial meningitis were highly suggestive of true infection.</p><p class=\"headingAnchor\" id=\"H688209454\"><span class=\"h2\">Skin, soft tissue, and bone infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter may contaminate surgical and traumatic wounds, leading to severe soft tissue infection that can also progress to osteomyelitis [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/105\" class=\"abstract_t\">105</a>]. Surgical wound infections with Acinetobacter are frequently related to the presence of prosthetic material and usually require extensive debridement. Acinetobacter has rarely been associated with community-acquired or hospital-acquired skin infections such as cellulitis and folliculitis as well as skin abscesses and necrotizing fasciitis [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/106-111\" class=\"abstract_t\">106-111</a>]. Traumatic wound infections due to multidrug-resistant Acinetobacter complex have been increasingly recognized after war injuries; environmental contamination of field hospitals appears to play an important role in these infections. (See <a href=\"#H11\" class=\"local\">'Wars and natural disasters'</a> above.)</p><p>Most Acinetobacter skin infections start with a skin break. Cellulitis starts as a well demarcated edematous patch with erythema, often having a peau d'orange appearance (<a href=\"image.htm?imageKey=ID%2F109231\" class=\"graphic graphic_picture graphicRef109231 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/112\" class=\"abstract_t\">112</a>]. It then transforms into a sandpaper-like lesion characterized by numerous vesicles that might later evolve into hemorrhagic bullae.</p><p class=\"headingAnchor\" id=\"H688209460\"><span class=\"h2\">Urinary tract infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The urinary tract can become colonized readily with Acinetobacter, particularly in the setting of indwelling urinary catheters; the incidence of infection is low [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/77,113\" class=\"abstract_t\">77,113</a>]. In a review of 5000 urinary tract infections in medical intensive care units in the United States, 1.6 percent was due to Acinetobacter; 95 percent of these infections were associated with urinary catheters [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/77\" class=\"abstract_t\">77</a>]. Community-acquired urinary tract infection can occur but is rare [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/114,115\" class=\"abstract_t\">114,115</a>].</p><p>In the absence of other signs or symptoms of infection, isolation of Acinetobacter may be attributed to colonization. </p><p class=\"headingAnchor\" id=\"H688209466\"><span class=\"h2\">Other infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acinetobacter can cause colonization or infection of the eye. Colonization has been observed in contact lens wearers [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/116\" class=\"abstract_t\">116</a>]. Ocular infection can include corneal ulcers, endophthalmitis, periorbital cellulitis, and infection after penetrating trauma [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/117-122\" class=\"abstract_t\">117-122</a>]. In one series including 750 cases of corneal ulcers, Acinetobacter was the third most common cause, accounting for 7 percent of cases [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/119\" class=\"abstract_t\">119</a>]. Most infections occurred postoperatively, usually following cataract surgery or other ocular surgeries. (See <a href=\"topic.htm?path=bacterial-endophthalmitis\" class=\"medical medical_review\">&quot;Bacterial endophthalmitis&quot;</a> and <a href=\"topic.htm?path=orbital-cellulitis\" class=\"medical medical_review\">&quot;Orbital cellulitis&quot;</a>.)</p><p>Acinetobacter can cause nosocomial sinusitis in patients admitted to the intensive care unit; mechanical ventilation is the most important predisposing factor [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/123,124\" class=\"abstract_t\">123,124</a>]. Acinetobacter sinusitis has been associated with the development of pneumonia, as the infected sinuses serve as reservoirs for dissemination to the lower respiratory tract [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/123\" class=\"abstract_t\">123</a>]. (See <a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis#H4\" class=\"medical medical_review\">&quot;Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis&quot;, section on 'Clinical features'</a>.)</p><p>Acinetobacter peritonitis has been described in patients undergoing peritoneal dialysis [<a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/125-127\" class=\"abstract_t\">125-127</a>]. The most common manifestations are abdominal pain and a cloudy dialysate. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-peritonitis-in-peritoneal-dialysis#H2\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis&quot;, section on 'Clinical presentation'</a>.)</p><p class=\"headingAnchor\" id=\"H962040163\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of Acinetobacter infection is made by the growth of Acinetobacter from a patient specimen (eg, sputum, blood, cerebrospinal fluid) in the setting of other clinical findings that suggest an infection at that site. Since Acinetobacter colonization is common and treatment difficult and potentially associated with substantial toxicity, distinction between colonization and infection, with treatment reserved for true infections, is important. As an example, Acinetobacter isolated from sputum of a ventilated patient is more likely to represent colonization than infection in the absence of fever, leukocytosis, increased respiratory secretions, need for additional respiratory support, or a new abnormality on chest imaging. For cases of pneumonia, quantitative or semiquantitative cultures on sputum specimens may also be helpful in distinguishing between infection and colonization. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnostic-evaluation-of-ventilator-associated-pneumonia#H2756495\" class=\"medical medical_review\">&quot;Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia&quot;, section on 'Diagnostic evaluation'</a>.)</p><p>The diagnoses of infections that have been associated with Acinetobacter spp are discussed in detail elsewhere:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=epidemiology-pathogenesis-microbiology-and-diagnosis-of-hospital-acquired-and-ventilator-associated-pneumonia-in-adults#H11\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired and ventilator-associated pneumonia in adults&quot;, section on 'Diagnosis'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-presentation-and-diagnostic-evaluation-of-ventilator-associated-pneumonia#H2756495\" class=\"medical medical_review\">&quot;Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia&quot;, section on 'Diagnostic evaluation'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diagnostic-approach-to-community-acquired-pneumonia-in-adults\" class=\"medical medical_review\">&quot;Diagnostic approach to community-acquired pneumonia in adults&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=blood-cultures-for-the-detection-of-bacteremia\" class=\"medical medical_review\">&quot;Blood cultures for the detection of bacteremia&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=gram-negative-bacillary-meningitis-epidemiology-clinical-features-and-diagnosis#H1788105587\" class=\"medical medical_review\">&quot;Gram-negative bacillary meningitis: Epidemiology, clinical features, and diagnosis&quot;, section on 'Diagnosis'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=complications-of-abdominal-surgical-incisions#H8\" class=\"medical medical_review\">&quot;Complications of abdominal surgical incisions&quot;, section on 'Clinical manifestations and diagnosis'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1214775\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The epidemiology of Acinetobacter infections is broad and includes hospital-acquired infection, community-acquired infections in tropical environments, and infections that occur in the setting of wars and natural disasters. Some strains can survive environmental desiccation for months, a characteristic that promotes transmission through fomite contamination in hospitals. (See <a href=\"#H4\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Health care-associated infections tend to occur in debilitated patients in intensive care units (among both children and adults) and among residents of long-term care facilities (particularly facilities caring for ventilator-dependent patients). Additional risk factors include recent surgery, central vascular catheterization, tracheostomy, mechanical ventilation, enteral feedings, and treatment with third generation cephalosporin, fluoroquinolone, or carbapenem antibiotics. (See <a href=\"#H6\" class=\"local\">'Health care-associated infections'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>More uncommonly, Acinetobacter is a cause of community-acquired infections. In particular, Acinetobacter has been described as a cause of severe community-acquired pneumonia in Australia and Asia, particularly during the wet season. Additionally, wartime Acinetobacter infections have been reported in the Korean War, the Vietnam War, and the wars in Iraq and Afghanistan. Acinetobacter infections have also been associated with natural disasters including tsunamis and earthquakes. (See <a href=\"#H10\" class=\"local\">'Community-acquired infection'</a> above and <a href=\"#H11\" class=\"local\">'Wars and natural disasters'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acinetobacter is easily isolated in standard cultures, although identification can be delayed since it is relatively nonreactive in many biochemical tests commonly used to differentiate among gram-negative bacilli. On Gram stain, Acinetobacter species appear as short, broad gram-negative rods in the rapid growth phase but assume a more coccobacillary shape in the stationary phase. (See <a href=\"#H962039848\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acinetobacter baumannii (genospecies 2 of the ACB complex) is the most resistant of the genospecies and has the greatest clinical importance. This pathogen is the most frequently isolated species (&gt;90 percent of Acinetobacter spp isolates) and is typically associated with outbreaks in the hospital setting. (See <a href=\"#H962039848\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hospital-acquired pneumonia and bloodstream infections are the most common infections associated with Acinetobacter. These Acinetobacter infections are associated with high mortality rates, partly because of prevalent comorbid conditions. Other less common infections include meningitis, wound or surgical site infections, and urinary tract infections. (See <a href=\"#H688208535\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of Acinetobacter infection is made by the growth of Acinetobacter from a patient specimen (eg, sputum, blood, cerebrospinal fluid) in the setting of other clinical findings that suggest an infection at that site. Acinetobacter can colonize skin, wounds, and the respiratory and gastrointestinal tracts. It is important but may be difficult to distinguish between colonization and true infection, particularly since many infections occur in the setting of colonization. (See <a href=\"#H962040163\" class=\"local\">'Diagnosis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006; 50:2941.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Leung WS, Chu CM, Tsang KY, et al. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006; 129:102.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Anstey NM, Currie BJ, Hassell M, et al. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002; 40:685.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Houang ET, Chu YW, Leung CM, et al. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol 2001; 39:228.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Chen MZ, Hsueh PR, Lee LN, et al. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 2001; 120:1072.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Berg DE, Hershow RC, Ramirez CA, Weinstein RA. Control of nosocomial infections in an intensive care unit in Guatemala City. Clin Infect Dis 1995; 21:588.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Ash RJ, Mauck B, Morgan M. Antibiotic resistance of gram-negative bacteria in rivers, United States. Emerg Infect Dis 2002; 8:713.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Gundi VA, Dijkshoorn L, Burignat S, et al. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 2009; 155:2333.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Eveillard M, Kempf M, Belmonte O, et al. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis 2013; 17:e802.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Albrecht MC, Griffith ME, Murray CK, et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 2006; 203:546.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Richards AM, Abu Kwaik Y, Lamont RJ. Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity. Mol Oral Microbiol 2015; 30:2.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann Periodontol 2003; 8:54.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Wendt C, Dietze B, Dietz E, R&uuml;den H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997; 35:1394.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Bernards AT, Harinck HI, Dijkshoorn L, et al. Persistent Acinetobacter baumannii? Look inside your medical equipment. Infect Control Hosp Epidemiol 2004; 25:1002.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Getchell-White SI, Donowitz LG, Gr&ouml;schel DH. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol 1989; 10:402.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003; 24:284.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009; 73:355.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel. J Med Microbiol 1997; 46:721.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">McDonald LC, Banerjee SN, Jarvis WR. Seasonal variation of Acinetobacter infections: 1987-1996. Nosocomial Infections Surveillance System. Clin Infect Dis 1999; 29:1133.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Munoz-Price LS, Arheart K, Nordmann P, et al. Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital. Crit Care Med 2013; 41:2733.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med 1998; 129:182.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000; 31:101.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Garnacho-Montero J, Ortiz-Leyba C, Fern&aacute;ndez-Hinojosa E, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005; 31:649.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Mittal N, Nair D, Gupta N, et al. Outbreak of Acinetobacter spp septicemia in a neonatal ICU. Southeast Asian J Trop Med Public Health 2003; 34:365.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Huang YC, Su LH, Wu TL, et al. Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis. Pediatr Infect Dis J 2002; 21:1105.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Hartstein AI, Rashad AL, Liebler JM, et al. Multiple intensive care unit outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated, reusable ventilator circuits and resuscitation bags. Am J Med 1988; 85:624.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Maragakis LL, Cosgrove SE, Song X, et al. An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004; 292:3006.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Marchaim D, Navon-Venezia S, Schwartz D, et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45:1551.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Naas T, Coignard B, Carbonne A, et al. VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006; 12:1214.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006; 44:3623.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Siempos II, Vardakas KZ, Kyriakopoulos CE, et al. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock 2010; 33:590.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Eberle BM, Schn&uuml;riger B, Putty B, et al. The impact of Acinetobacter baumannii infections on outcome in trauma patients: a matched cohort study. Crit Care Med 2010; 38:2133.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Dizbay M, Tunccan OG, Sezer BE, Hizel K. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scand J Infect Dis 2010; 42:741.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Metan G, Sariguzel F, Sumerkan B. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur J Intern Med 2009; 20:540.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Davis JS, McMillan M, Swaminathan A, et al. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Chest 2014; 146:1038.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Anstey NM, Currie BJ, Withnall KM. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis 1992; 14:83.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Wang JT, McDonald LC, Chang SC, Ho M. Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan. J Clin Microbiol 2002; 40:1526.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Cordes LG, Brink EW, Checko PJ, et al. A cluster of Acinetobacter Pneumonia in foundry workers. Ann Intern Med 1981; 95:688.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:1063.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44:1577.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">LINDBERG RB, WETZLER TF, MARSHALL JD, et al. The bacterial flora of battle wounds at the time of primary debridement; a study of the Korean battle casualty. Ann Surg 1955; 141:369.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Murray CK, Yun HC, Griffith ME, et al. Acinetobacter infection: what was the true impact during the Vietnam conflict? Clin Infect Dis 2006; 43:383.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Hawley JS, Murray CK, Griffith ME, et al. Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob Agents Chemother 2007; 51:376.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Sheppard FR, Keiser P, Craft DW, et al. The majority of US combat casualty soft-tissue wounds are not infected or colonized upon arrival or during treatment at a continental US military medical facility. Am J Surg 2010; 200:489.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Griffith ME, Lazarus DR, Mann PB, et al. Acinetobacter skin carriage among US army soldiers deployed in Iraq. Infect Control Hosp Epidemiol 2007; 28:720.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Hujer KM, Hujer AM, Hulten EA, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 2006; 50:4114.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Maegele M, Gregor S, Steinhausen E, et al. The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects. Crit Care Med 2005; 33:1136.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Onc&uuml;l O, Keskin O, Acar HV, et al. Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect 2002; 51:47.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Juni E. Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus. J Bacteriol 1972; 112:917.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">BRISOU J, PREVOT AR. [Studies on bacterial taxonomy. X. The revision of species under Acromobacter group]. Ann Inst Pasteur (Paris) 1954; 86:722.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Ingram M, Shewan JW. Introductory reflections on the Pseudomonas-Achromobacter group. J Appl Bacteriol 1960; 23:373.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Dijkshoorn L, van der Toorn J. Acinetobacter species: which do we mean? Clin Infect Dis 1992; 15:748.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010; 23:332.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2010; 35:219.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008; 358:1271.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Zarrilli R, Giannouli M, Tomasone F, et al. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries 2009; 3:335.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991; 29:277.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Chuang YC, Sheng WH, Li SY, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis 2011; 52:352.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Seifert H, Baginski R, Schulze A, Pulverer G. The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol 1993; 279:544.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Juni E. Genetics and physiology of Acinetobacter. Annu Rev Microbiol 1978; 32:349.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Hung YT, Lee YT, Huang LJ, et al. Clinical characteristics of patients with Acinetobacter junii infection. J Microbiol Immunol Infect 2009; 42:47.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Greene C, Vadlamudi G, Newton D, et al. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control 2016; 44:e65.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Kaplan N, Rosenberg E, Jann B, Jann K. Structural studies of the capsular polysaccharide of Acinetobacter calcoaceticus BD4. Eur J Biochem 1985; 152:453.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Goel VK, Kapil A. Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol 2001; 1:16.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis 2016.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/69\" class=\"nounderline abstract_t\">Fagon JY, Chastre J, Domart Y, et al. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis 1996; 23:538.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/71\" class=\"nounderline abstract_t\">Garnacho-Montero J, Ortiz-Leyba C, Jim&eacute;nez-Jim&eacute;nez FJ, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36:1111.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13:97.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">Garnacho J, Sole-Violan J, Sa-Borges M, et al. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 2003; 31:2478.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/74\" class=\"nounderline abstract_t\">Brotfain E, Borer A, Koyfman L, et al. Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome. J Intensive Care Med 2016.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/75\" class=\"nounderline abstract_t\">&Ouml;zvatan T, Akal&#305;n H, S&#305;n&#305;rta&#351; M, et al. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases. Respirology 2016; 21:363.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/76\" class=\"nounderline abstract_t\">Ong CW, Lye DC, Khoo KL, et al. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 2009; 14:1200.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/77\" class=\"nounderline abstract_t\">Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41:848.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/78\" class=\"nounderline abstract_t\">Wisplinghoff H, Edmond MB, Pfaller MA, et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000; 31:690.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/79\" class=\"nounderline abstract_t\">Cisneros JM, Rodr&iacute;guez-Ba&ntilde;o J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8:687.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/80\" class=\"nounderline abstract_t\">Chen HP, Chen TL, Lai CH, et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005; 38:127.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/81\" class=\"nounderline abstract_t\">Cisneros JM, Reyes MJ, Pach&oacute;n J, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996; 22:1026.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/82\" class=\"nounderline abstract_t\">Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995; 74:340.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/83\" class=\"nounderline abstract_t\">Garc&iacute;a-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 2001; 33:939.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/84\" class=\"nounderline abstract_t\">G&oacute;mez J, Simarro E, Ba&ntilde;os V, et al. Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1999; 18:358.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/85\" class=\"nounderline abstract_t\">Tilley PA, Roberts FJ. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis 1994; 18:896.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/86\" class=\"nounderline abstract_t\">Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect Control Hosp Epidemiol 2007; 28:293.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/87\" class=\"nounderline abstract_t\">Lee YT, Kuo SC, Yang SP, et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis 2012; 55:209.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/88\" class=\"nounderline abstract_t\">Guo N, Xue W, Tang D, et al. Risk factors and outcomes of hospitalized patients with blood infections caused by multidrug-resistant Acinetobacter baumannii complex in a hospital of Northern China. Am J Infect Control 2016; 44:e37.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/89\" class=\"nounderline abstract_t\">Gradon JD, Chapnick EK, Lutwick LI. Infective endocarditis of a native valve due to Acinetobacter: case report and review. Clin Infect Dis 1992; 14:1145.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/90\" class=\"nounderline abstract_t\">Valero C, Fari&ntilde;as MC, Garc&iacute;a Palomo D, et al. Endocarditis due to Acinetobacter lwoffi on native mitral valve. Int J Cardiol 1999; 69:97.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/91\" class=\"nounderline abstract_t\">Rizos I, Tsiodras S, Papathanasiou S, et al. Prosthetic valve endocarditis due to Acinetobacter spp: a rare case and literature review. Am J Med Sci 2007; 333:197.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/92\" class=\"nounderline abstract_t\">Malik AS. Acinetobacter endocarditis in children: a case report and review of the literature. Infection 1995; 23:306.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/93\" class=\"nounderline abstract_t\">Fang G, Keys TF, Gentry LO, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med 1993; 119:560.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/94\" class=\"nounderline abstract_t\">Korinek AM, Baugnon T, Golmard JL, et al. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 2006; 59:126.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/95\" class=\"nounderline abstract_t\">Chen SF, Chang WN, Lu CH, et al. Adult Acinetobacter meningitis and its comparison with non-Acinetobacter gram-negative bacterial meningitis. Acta Neurol Taiwan 2005; 14:131.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/96\" class=\"nounderline abstract_t\">Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 2003; 21:58.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/97\" class=\"nounderline abstract_t\">Rodr&iacute;guez Guardado A, Maradona JA, Asensi V, et al. [Postsurgical meningitis caused by Acinetobacter baumannii: study of 22 cases and review of the literature]. Rev Clin Esp 2001; 201:497.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/98\" class=\"nounderline abstract_t\">Chen HP, Lai CH, Chan YJ, et al. Clinical significance of Acinetobacter species isolated from cerebrospinal fluid. Scand J Infect Dis 2005; 37:669.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/99\" class=\"nounderline abstract_t\">Siegman-Igra Y, Bar-Yosef S, Gorea A, Avram J. Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin Infect Dis 1993; 17:843.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/100\" class=\"nounderline abstract_t\">Kelkar R, Gordon SM, Giri N, et al. Epidemic iatrogenic Acinetobacter spp. meningitis following administration of intrathecal methotrexate. J Hosp Infect 1989; 14:233.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/101\" class=\"nounderline abstract_t\">Wroblewska MM, Dijkshoorn L, Marchel H, et al. Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J Hosp Infect 2004; 57:300.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/102\" class=\"nounderline abstract_t\">Ng J, Gosbell IB, Kelly JA, et al. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006; 58:1078.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/103\" class=\"nounderline abstract_t\">Chang WN, Lu CH, Huang CR, Chuang YC. Community-acquired Acinetobacter meningitis in adults. Infection 2000; 28:395.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/104\" class=\"nounderline abstract_t\">Gusten WM, Hansen EA, Cunha BA. Acinetobacter baumannii pseudomeningitis. Heart Lung 2002; 31:76.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/105\" class=\"nounderline abstract_t\">Davis KA, Moran KA, McAllister CK, Gray PJ. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 2005; 11:1218.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/106\" class=\"nounderline abstract_t\">Glew RH, Moellering RC Jr, Kunz LJ. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies. Medicine (Baltimore) 1977; 56:79.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/107\" class=\"nounderline abstract_t\">Chiang WC, Su CP, Hsu CY, et al. Community-acquired bacteremic cellulitis caused by Acinetobacter baumannii. J Formos Med Assoc 2003; 102:650.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/108\" class=\"nounderline abstract_t\">Bachmeyer C, Landgraf N, Cordier F, et al. Acinetobacter baumanii folliculitis in a patient with AIDS. Clin Exp Dermatol 2005; 30:256.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/109\" class=\"nounderline abstract_t\">Ng G, Sharma BK, Fox GF. Acinetobacter skin abscess in a neonate. J Perinatol 2004; 24:526.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/110\" class=\"nounderline abstract_t\">Adler BL, Krausz A, Friedman AJ. Acinetobacter baumannii emerging as a multidrug-resistant skin and soft-tissue pathogen: parallels to methicillin-resistant Staphylococcus aureus. JAMA Dermatol 2014; 150:905.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/111\" class=\"nounderline abstract_t\">Sinha N, Niazi M, Lvovsky D. A fatal case of multidrug resistant acinetobacter necrotizing fasciitis: the changing scary face of nosocomial infection. Case Rep Infect Dis 2014; 2014:705279.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/112\" class=\"nounderline abstract_t\">Sebeny PJ, Riddle MS, Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis 2008; 47:444.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/113\" class=\"nounderline abstract_t\">Turnidge J, Bell J, Biedenbach DJ, Jones RN. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents 2002; 20:10.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/114\" class=\"nounderline abstract_t\">Hoffmann S, Mabeck CE, Vejlsgaard R. Bacteriuria caused by Acinetobacter calcoaceticus biovars in a normal population and in general practice. J Clin Microbiol 1982; 16:443.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/115\" class=\"nounderline abstract_t\">Lau SM, Peng MY, Chang FY. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect 2004; 37:185.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/116\" class=\"nounderline abstract_t\">Corrigan KM, Harmis NY, Willcox MD. Association of acinetobacter species with contact lens-induced adverse responses. Cornea 2001; 20:463.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/117\" class=\"nounderline abstract_t\">Wang AG, Wu CC, Liu JH. Bacterial corneal ulcer: a multivariate study. Ophthalmologica 1998; 212:126.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/118\" class=\"nounderline abstract_t\">Gopal L, Ramaswamy AA, Madhavan HN, et al. Postoperative endophthalmitis caused by sequestered Acinetobacter calcoaceticus. Am J Ophthalmol 2000; 129:388.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/119\" class=\"nounderline abstract_t\">Mahajan VM. Postoperative ocular infections: an analysis of laboratory data on 750 cases. Ann Ophthalmol 1984; 16:847.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/120\" class=\"nounderline abstract_t\">Mark DB, Gaynon MW. Trauma-induced endophthalmitis caused by Acinetobacter anitratus. Br J Ophthalmol 1983; 67:124.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/121\" class=\"nounderline abstract_t\">Miller J. Acinetobacter as a causative agent in preseptal cellulitis. Optometry 2005; 76:176.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/122\" class=\"nounderline abstract_t\">Mathews D, Mathews JP, Kwartz J, Inkster C. Preseptal cellulitis caused by Acinetobacter lwoffi. Indian J Ophthalmol 2005; 53:213.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/123\" class=\"nounderline abstract_t\">Bert F, Lambert-Zechovsky N. Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 1996; 15:533.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/124\" class=\"nounderline abstract_t\">Pneumatikos I, Konstantonis D, Tsagaris I, et al. Prevention of nosocomial maxillary sinusitis in the ICU: the effects of topically applied alpha-adrenergic agonists and corticosteroids. Intensive Care Med 2006; 32:532.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/125\" class=\"nounderline abstract_t\">Dandecha P, Sangthawan P. Peritonitis in acute peritoneal dialysis in a university hospital. J Med Assoc Thai 2002; 85:477.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/126\" class=\"nounderline abstract_t\">Galvao C, Swartz R, Rocher L, et al. Acinetobacter peritonitis during chronic peritoneal dialysis. Am J Kidney Dis 1989; 14:101.</a></li><li><a href=\"https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis/abstract/127\" class=\"nounderline abstract_t\">Valdez JM, Asperilla MO, Smego RA Jr. Acinetobacter peritonitis in patients receiving continuous ambulatory peritoneal dialysis. South Med J 1991; 84:607.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3121 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1214775\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">EPIDEMIOLOGY</a><ul><li><a href=\"#H960943695\" id=\"outline-link-H960943695\">Association with climate</a></li><li><a href=\"#H960943549\" id=\"outline-link-H960943549\">Disease associations</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Health care-associated infections</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Community-acquired infection</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Wars and natural disasters</a></li></ul></li></ul></li><li><a href=\"#H962039848\" id=\"outline-link-H962039848\">MICROBIOLOGY</a></li><li><a href=\"#H962039894\" id=\"outline-link-H962039894\">PATHOGENESIS</a></li><li><a href=\"#H688208535\" id=\"outline-link-H688208535\">CLINICAL FEATURES</a><ul><li><a href=\"#H688209418\" id=\"outline-link-H688209418\">Hospital-acquired pneumonia</a></li><li><a href=\"#H688209430\" id=\"outline-link-H688209430\">Community-acquired pneumonia</a></li><li><a href=\"#H688209436\" id=\"outline-link-H688209436\">Bloodstream infection</a><ul><li><a href=\"#H688209442\" id=\"outline-link-H688209442\">- Endocarditis</a></li></ul></li><li><a href=\"#H688209448\" id=\"outline-link-H688209448\">Meningitis</a></li><li><a href=\"#H688209454\" id=\"outline-link-H688209454\">Skin, soft tissue, and bone infection</a></li><li><a href=\"#H688209460\" id=\"outline-link-H688209460\">Urinary tract infection</a></li><li><a href=\"#H688209466\" id=\"outline-link-H688209466\">Other infections</a></li></ul></li><li><a href=\"#H962040163\" id=\"outline-link-H962040163\">DIAGNOSIS</a></li><li><a href=\"#H1214775\" id=\"outline-link-H1214775\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3121|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/109231\" class=\"graphic graphic_picture\">- Acinetobacter leg infection</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acinetobacter-infection-treatment-and-prevention\" class=\"medical medical_review\">Acinetobacter infection: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-endophthalmitis\" class=\"medical medical_review\">Bacterial endophthalmitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=blood-cultures-for-the-detection-of-bacteremia\" class=\"medical medical_review\">Blood cultures for the detection of bacteremia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-acute-bacterial-meningitis-in-adults\" class=\"medical medical_review\">Clinical features and diagnosis of acute bacterial meningitis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-peritonitis-in-peritoneal-dialysis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnostic-evaluation-of-ventilator-associated-pneumonia\" class=\"medical medical_review\">Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=complications-of-abdominal-surgical-incisions\" class=\"medical medical_review\">Complications of abdominal surgical incisions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-approach-to-community-acquired-pneumonia-in-adults\" class=\"medical medical_review\">Diagnostic approach to community-acquired pneumonia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-prosthetic-valve-endocarditis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-microbiology-and-diagnosis-of-hospital-acquired-and-ventilator-associated-pneumonia-in-adults\" class=\"medical medical_review\">Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired and ventilator-associated pneumonia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gram-negative-bacillary-bacteremia-in-adults\" class=\"medical medical_review\">Gram-negative bacillary bacteremia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gram-negative-bacillary-meningitis-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Gram-negative bacillary meningitis: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gram-negative-bacillary-meningitis-treatment\" class=\"medical medical_review\">Gram-negative bacillary meningitis: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=orbital-cellulitis\" class=\"medical medical_review\">Orbital cellulitis</a></li></ul></div></div>","javascript":null}